智通财经6月12日电，台基股份(300046.SZ)公告称，公司控股股东新仪元及实际控制人邢雁正在筹划公 司控制权变更相关事宜，可能导致公司实际控制人发生变更。为保证公平信息披露，避免股价异常波 动，公司股票自2025年6月13日起停牌，预计停牌时间不超过2个交易日。目前各方尚未签署相关协议， 具体方案存在不确定性。 台基股份：控股股东、实控人筹划公司控制权变更相关事宜 股票停牌 ...

本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏。 特别提示： 1、湖北台基半导体股份有限公司（以下简称"公司"）控股股东襄阳新仪元 半导体有限责任公司（以下简称"新仪元"）及实际控制人邢雁先生正在筹划公司 控制权变更相关事宜，该事项可能导致公司实际控制人发生变更。为保证公平信 息披露，避免公司股价异常波动，维护广大投资者利益，经公司向深圳证券交易 所申请，公司股票（证券代码：300046，证券简称：台基股份）自2025年6月13 日（星期五）开市起停牌，预计停牌时间不超过2个交易日。 证券代码：300046 证券简称：台基股份 公告编号：2025-032 湖北台基半导体股份有限公司 关于筹划控制权变更暨停牌的公告 1 （www.cninfo.com.cn），公司所有信息均以在上述指定媒体刊登的信息为准。 因该事项存在不确定性，敬请投资者关注相关公告并注意投资风险。 特此公告。 湖北台基半导体股份有限公司 董 事 会 2025 年 6 月 12 日 2、本次交易事项能否最终实施完成及实施结果尚存在不确定性。敬请广大 投资者关注后续公告并注意投资风险。 公司于20 ...

| | □特定对象调研□分析师会议 | | --- | --- | | | □媒体采访□业绩说明会 | | 投资者关系 | □新闻发布会□路演活动 | | 活动类别 | | | | □现场参观□电话会议 | | | √其他湖北辖区上市公司 2025 年投资者集体接待日 | | 参与单位名称及人 | 投资者网上提问 | | 员姓名 | | | 时间 | 年 月 日（周四）下午 2025 6 12 14:30~16:50 | | | 公司通过全景网"投资者关系互动平台"（https://ir.p5w.net） | | 地点 | 采用网络远程的方式参加湖北辖区上市公司 2025 年投资者集体接 | | | 待日 | | 上市公司 | 董事兼财务总监：吴建林 | | 接待人员姓名 | 董事会秘书兼副总经理：康进 | | | 公司于 年 月 日采用网络远程方式参加湖北辖区上市 2025 6 12 | | | 公司 2025 年投资者集体接待日，公司与投资者进行了互动交流与 | | | 沟通。公司与投资者交流的主要内容如下： | | | 1、说说近期的展望，有没有什么新的计划。有没有并购重组的计 | | | 划。 | | ...

Group 1 - Huapei Power received a project intention letter from a domestic new energy vehicle company for a thermal management system PTC water heater, with an estimated sales amount of approximately 9 million yuan over a 5-year lifecycle starting from 2026 [1] - Antu Biotech obtained medical device registration certificates for products including "Cytomegalovirus IgM Antibody Test Kit" [1][2] - Yihong Technology adjusted the upper limit of its share repurchase price to 65.04 yuan per share, with a total repurchase amount of 6.9583 million yuan for 198,000 shares [2] Group 2 - Aihui Long received a medical device registration certificate for the Hepatitis B virus core antibody detection kit, valid until May 28, 2030 [2][3] - Quanxin Co. plans to engage in commodity futures hedging to mitigate raw material price fluctuations, with a maximum guarantee amount of 8 million yuan [3] - Jiahua Intelligent plans to lease idle assets in Dongguan for a total rental amount of approximately 6.3193 million yuan over 6 years [3] Group 3 - Qianjiang Biochemical announced the resignation of its chairman and a director, with a new chairman to be elected [4][5] - Aerospace Morning Light was suspended from participating in military procurement activities due to violations, with internal investigations underway [6] - Guang'an Aizhong intends to establish a fund with a total scale of 70.7 million yuan, focusing on distributed wind and solar power generation [7] Group 4 - Zhejiang Medicine plans to use up to 1 billion yuan of idle funds for entrusted wealth management, with a maximum investment period of 12 months [10] - Hengrui Medicine's subsidiary received approval for clinical trials of HRS9531 injection, aimed at treating type 2 diabetes patients [11] - Taiji Co. announced the purchase of 10 million yuan in wealth management products, with a minimum holding period of 6 months [12] Group 5 - Hong Kong-listed company Huichuang Pharmaceutical received approval for the clinical trial of a spray for treating primary premature ejaculation [26][27] - Haichuang Pharmaceutical's new drug application for a prostate cancer treatment was approved by the National Medical Products Administration [28] - Zhuhai Guanyu was selected as a designated supplier for low-voltage lithium batteries by SAIC Volkswagen [29] Group 6 - Huayi Technology opened a tax refund service for overseas travelers, enhancing its retail offerings [32] - Baobian Electric plans to transfer 90% of its subsidiary's shares for 137 million yuan [33] - Yiwei Communication intends to invest 100 million yuan to establish a wholly-owned subsidiary to enhance its strategic layout [34]

证券代码：300046 证券简称：台基股份 公告编号：2025-031 湖北台基半导体股份有限公司 关于使用闲置资金购买理财产品的公告 按照公司年度闲置资金理财计划，公司继续使用部分暂时闲置的自有资金进 行委托理财。现就相关事宜公告如下： 一、本次理财产品的购买情况 公司使用暂时闲置的自有资金1,000万元购买了中泰双鑫6个月持有期债券型 证券投资基金，具体情况如下： （1）产品名称：中泰双鑫6个月持有期债券型证券投资基金 （2）产品类型：债券型证券投资基金 （3）运作方式：契约型开放式 （4）签约方：中泰证券（上海）资产管理有限公司（管理人）、招商银行股 份有限公司（托管人） 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏。 湖北台基半导体股份有限公司（以下简称"公司"）2024年年度股东大会审 议通过了《关于使用暂时闲置自有资金进行委托理财的议案》，同意公司使用总 额不超过60,000万元暂时闲置的自有资金进行委托理财，在上述额度内，资金可 以滚动使用（详见公司2025年4月3日在巨潮资讯网发布的相关公告，编号为 2025-016）。 （5）金额：1,00 ...

证券代码：300046 证券简称：台基股份 公告编号：2025-030 湖北台基半导体股份有限公司 2024 年年度权益分派实施公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏。 湖北台基半导体股份有限公司（以下简称"公司"）2024 年年度权益分派方 案已获 2025 年 4 月 24 日召开的 2024 年年度股东大会审议通过，现将权益分派 事宜公告如下： 一、 股东大会审议通过利润分配方案情况 二、 本次实施的权益分派方案 公司2024年年度权益分派方案为：以公司现有总股本236,531,371股为基数， 向全体股东每 10 股派 0.80 元人民币现金（含税；扣税后，通过深股通持有股份 的香港市场投资者、境外机构（含 QFII、RQFII）以及持有首发前限售股的个人 和证券投资基金每 10 股派 0.72 元；持有首发后限售股、股权激励限售股及无限 1 2024 年年度权益分派实施公告 1、公司 2024 年年度股东大会审议通过的 2024 年度利润分配方案为：以公 司总股本 236,531,371 股为基数，每 10 股派发现金股利 0.8 元（ ...

Core Viewpoint - The EDA (Electronic Design Automation) concept stocks experienced a significant surge in opening prices, indicating strong market interest and potential growth in this sector [1] Group 1: Stock Performance - The stock of Shentong Metro reached its daily limit up during the bidding process [1] - Companies such as Gelun Electronics, Huada Jiutian, and Guangliwei saw their stock prices increase by over 10% [1] - Other companies like Anlu Technology and Taiji Co. also experienced upward movement in their stock prices [1]

Group 1 - Huiyu Pharmaceutical's subsidiary received drug registration certificate for Carboxymethyl Sodium Injection, which is used for treating bleeding diseases in various medical fields [1] - Baihe Co., Ltd. announced a plan for a director to reduce holdings by up to 424,000 shares, representing 0.6625% of the total share capital [1] - Kingood Co., Ltd. received a notification from a global leading automaker for a wheel project, expected to start mass production in 2026 with a lifecycle of 10 years [1][2] Group 2 - Wanhua Chemical plans to repurchase shares worth between 300 million and 500 million yuan, with a maximum repurchase price of 99.36 yuan per share [2] - Warner Pharmaceutical's subsidiary received approval for Acetylcysteine raw material drug, primarily used for treating respiratory diseases [3] - ST Mingcheng plans to publicly transfer 45% equity of its subsidiary, aiming to optimize asset structure [4] Group 3 - Qixia Construction announced a plan to reduce up to 31.5 million shares, accounting for 3% of total share capital [5][6] - Zhejiang Rongtai intends to invest 20 million yuan to establish a wholly-owned subsidiary focused on intelligent robotics [7] - Yuandong Biological received drug registration for Chloral Hydrate Enema, used for sedation and seizure control in children [9] Group 4 - Jiemai Technology's subsidiary signed a strategic cooperation agreement with a solid-state battery company to produce high-safety composite conductive materials [10] - Xianju Pharmaceutical received drug registration for Progesterone Soft Capsules, used for treating functional disorders due to luteal deficiency [11] - Lanhua Kecai's subsidiary reported a temporary production halt, with the resumption date yet to be determined [13] Group 5 - Sinopharm Modern's subsidiary received drug registration for Tocilizumab Tablets, used for treating rheumatoid arthritis and other conditions [15] - Shanghai Bank announced the resignation of its vice president due to organizational adjustments [17] - Shanghai Pharmaceutical's Ephedrine Injection passed the consistency evaluation for generic drugs [19] Group 6 - Rundu Co., Ltd. received drug registration for Amlodipine and Olmesartan Tablets, aimed at treating hypertension [21] - Zhong'an Technology announced that 61 million shares held by its controlling shareholder will be auctioned [23] - Shanghai Washba plans to purchase patent assets and establish two subsidiaries focused on hydrogen energy and solid-state battery technologies [25] Group 7 - Nuo Cheng Jianhua's new drug Tafasitamab received approval for treating relapsed/refractory diffuse large B-cell lymphoma [26] - Benli Technology plans to use up to 200 million yuan of idle funds for cash management and financial investments [28] - Taiji Co., Ltd. intends to use 60 million yuan of idle funds to purchase financial products [29] Group 8 - Haishi Co. announced that its innovative drug Anreke Fen Injection received drug registration for treating postoperative pain [32] - Yulong Co. will have its stock delisted on May 27, 2025, following a decision by the Shanghai Stock Exchange [36] - Weifu High-Tech plans to establish a joint venture with Shanghai Baolong Automotive Technology [38] Group 9 - Xichang Electric Power expects a net profit reduction of approximately 5.4 million yuan due to adjustments in the time-of-use electricity pricing mechanism [39] - Alter signed a contract worth 6.8 billion yen for the development and procurement of large truck EV kits [41] - Zhonglian Heavy Industry plans to acquire controlling stakes in its financing leasing subsidiary through public bidding [42] Group 10 - Sanyou Medical's executive plans to reduce holdings by up to 1.44% of the company's shares [43] - Hangyang Co. plans to establish a subsidiary for large modular cryogenic equipment manufacturing with an estimated investment of 557 million yuan [44] - FAW Fuwi received a notification for a dashboard project from a well-known new energy brand, with total sales expected to reach 1.06 billion yuan [45]

证券代码：300046 证券简称：台基股份 公告编号：2025-029 湖北台基半导体股份有限公司 公司对部分闲置的自有资金购买的理财产品进行到期赎回，按照公司年度闲 置资金理财计划，公司继续使用部分暂时闲置的自有资金进行委托理财。现就相 关事宜公告如下： 一、本次理财产品的购买情况 1、公司使用暂时闲置的自有资金3,000万元购买了省心享-华泰WEFUND企业 家台基致远私享FOF56号单一资产管理计划，具体情况如下： （1）产品名称：省心享-华泰WEFUND企业家台基致远私享FOF56号单一资 产管理计划 （4）签约方：华泰证券（上海）资产管理有限公司（管理人）、招商银行股 份有限公司武汉分行（托管人） 关于使用闲置资金购买理财产品的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏。 湖北台基半导体股份有限公司（以下简称"公司"）2024年年度股东大会审 议通过了《关于使用暂时闲置自有资金进行委托理财的议案》，同意公司使用总 额不超过60,000万元暂时闲置的自有资金进行委托理财，在上述额度内，资金可 以滚动使用（详见公司2025年4月3日在巨潮资讯网 ...

证券代码：300046 证券简称：台基股份 公告编号：2025-028 湖北台基半导体股份有限公司 关于对外投资暨关联交易的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏。 湖北台基半导体股份有限公司（以下简称"公司"）于 2025 年 4 月 23 日召开 第六届董事会第八次会议和第六届监事会第七次会议，审议通过《关于对外投资 暨关联交易的议案》，同意公司与中国工程物理研究院流体物理研究所、湖北海普 锐能企业管理合伙企业（有限合伙）、襄阳襄水云合企业管理合伙企业（有限合伙） 共同投资设立湖北晶脉科技有限公司（暂定名，以市场监督管理部门最终核准的 名称为准）。具体内容详见公司于 2025 年 4 月 24 日披露在巨潮资讯网上的相关公 告。 一、进展情况 近日，湖北晶脉科技有限公司完成了工商注册登记手续，并取得襄阳市市场 监督管理局下发的《营业执照》。具体信息如下： 名称：湖北晶脉科技有限公司 法定代表人：朱玉德 成立日期：2025 年 5 月 19 日 1 统一社会信用代码：91420602MAEL991CXJ 类型：其他有限责任公司 注册资本：壹 ...